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Background: The lung is constantly exposed to environmental challenges and must rapidly respond to external
insults. Mechanisms involved in the repair of the damaged lung involve expansion of different epithelial cells
to repopulate the injured cellular compartment. However, factors regulating cell proliferation following lung
injury remain poorly understood. Here we studied the role of the transcriptional regulator Lmo4 during lung
development, in the regulation of adult lung epithelial cell proliferation following lung damage and in the context
of oncogenic transformation.
Methods: To study the role of Lmo4 in embryonic lung development, lung repair and tumorigenesis, we used
conditional knock-out mice to delete Lmo4 in lung epithelial cells from the first stages of lung development. The
role of Lmo4 in lung repair was evaluated using two experimental models of lung damage involving chemical and
viral injury. The role of Lmo4 in lung tumorigenesis was measured using a mouse model of lung adenocarcinoma
in which the oncogenic K-Ras protein has been knocked into the K-Ras locus. Overall survival difference between
genotypes was tested by log rank test. Difference between means was tested using one-way ANOVA after assuring
that assumptions of normality and equality of variance were satisfied.
Results: We found that Lmo4 was not required for normal embryonic lung morphogenesis. In the adult lung, loss
of Lmo4 reduced epithelial cell proliferation and delayed repair of the lung following naphthalene or flu-mediated
injury, suggesting that Lmo4 participates in the regulation of epithelial cell expansion in response to cellular
damage. In the context of K-RasG12D-driven lung tumor formation, Lmo4 loss did not alter overall survival but
delayed initiation of lung hyperplasia in K-RasG12D mice sensitized by naphthalene injury. Finally, we evaluated the
expression of LMO4 in tissue microarrays of early stage non-small cell lung cancer and observed that LMO4 is more
highly expressed in lung squamous cell carcinoma compared to adenocarcinoma.
Conclusions: Together these results show that the transcriptional regulator Lmo4 participates in the regulation of
lung epithelial cell proliferation in the context of injury and oncogenic transformation but that Lmo4 depletion is
not sufficient to prevent lung repair or tumour formation.
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The regulator of transcription LMO4 is a member of the
LIM-domain only (LMO) protein family that act as mo-
lecular adaptors, providing a scaffold for multiprotein
complexes of DNA-binding factors and transcriptional
regulatory proteins [1–4]. LMO4 modulates neuronal
progenitor cell proliferation and inhibits differentiation of
mammary epithelial cells, suggesting that it may partici-
pate in the regulation of progenitor cell function [2, 5].
LMO4 is highly expressed in epithelial cells, often at loca-
tion of active mesenchymal-epithelial interactions, such as
hair follicles, teeth, epidermis, mammary gland, kidney,
and lung [6–9] suggesting that LMO4 may modulate the
function of DNA-binding proteins in signaling pathways
involved in mesenchymal-epithelial cross-talk. LMO4 in-
teracts with Smad proteins and increases the effect of
TGFβ on epithelial cell growth [10]. Mice lacking Lmo4
die perinatally from complex phenotypic abnormalities,
with approximately 50 % of mice exhibiting exencephaly.
Mice that do not display exencephaly are pale at birth,
gasping for air and die shortly after birth [11]. Deregula-
tion of LMO4 has been described in several tumor types
including breast, prostate, pancreas, lung and squamous
cell carcinoma of the oral cavity [2, 12–16]. LMO4 is
overexpressed in more than 50 % of breast cancers and
high nuclear expression of LMO4 has been found to be
a predictor of worse outcome in breast cancer patients
[3]. Down-regulation of LMO4 reduced proliferation of
human breast cancer cells and increased differentiation
of mouse mammary epithelial cells while overexpression
of LMO4 in non-invasive, immortalised human cells
promoted cell motility and invasion [3], suggesting that
Lmo4 may play a role in epithelial cell proliferation and
differentiation.
The lung is constantly exposed to toxic agents and
pathogens present in the environment and must activate
a number of molecular and cellular processes to induce
rapid cell proliferation and repair. It is becoming evident
that distinct types of lung stem/progenitor cells are acti-
vated depending on the type of injury inflicted to the
lung [17]. Experimental protocols using chemical agents,
viruses, or diffusible gases, have been used in mouse
models to study the activation of lung stem cells in re-
sponse to environmental challenges. Each model is unique
in the type of injury caused as reflected by the degree of
immune cell infiltration, fibrosis and the cell types affected
[18, 19]. Specifically, administration of H1N1 flu virus to
animals leads to broad damage of epithelial cell types in
the lung including club cells, ciliated cells, as well as al-
veolar cells. Damage and repair of the lung after H1N1 in-
fection occurs in the absence of fibrosis as opposed to
bleomycin treatment that induces extensive fibrosis [20].
A rare population of distal lung basal progenitor cells with
regenerative capacity has been identified and shown to beresponsible for the repair of the lung after H1N1 injury.
Lineage tracing experiments and transplantation assays
demonstrated that these rare distal basal cells expanded
after injury and gave rise to club cells, ciliated cells and al-
veolar cells [21, 22]. Vaughan et al. indicated that these
progenitor cells did not express lung lineage specific
markers but were present in a subset of cells expressing
integrin β4 (CD104) but negative for the club cell marker
CC10 [22]. In the non-injured lung, cells expressing the
laminin receptor integrin α6β4 were shown to be enriched
for cells with colony forming capacity in vitro [23, 24],
suggesting they behaved as progenitor cells in the distal
lung. Chemical injury induced by administration of
naphthalene, a component found in tobacco smoke,
leads to the ablation of the large majority of club cells
(Cyp2f2+). Only a small number of these cells, named
variant club cells, that do not express Cyp2f2 resist in-
jury and are thought to be the progenitor cells respon-
sible for repair of the airways [25, 26]. Naphthalene
injury has also been shown to accelerate tumour growth
when combined with oncogenic alterations such as ex-
pression of K-RasG12D [27]. Factors involved in the regu-
lation of the different classes of progenitor cells in the
lung remain poorly characterised.
The observation that Lmo4 knockout mice display
breathing difficulty at birth and that LMO4 is overex-
pressed in advanced lung cancer prompted us to explore
its role in lung morphogenesis, adult lung repair and
cancer. We used conditional knock-out mice to ablate
Lmo4 expression in the lung epithelium from E9.5 and
found that Shh-cre;Lmo4fl/fl mice were viable and healthy.
However, we observed that Lmo4 loss reduced prolifera-
tion of adult lung epithelial cells and delayed repair fol-
lowing virus-induced and chemical-induced lung injury.
We then examined the role of Lmo4 in lung tumorigen-
esis by deleting Lmo4 in mice expressing the oncogenic
K-RasG12D. Our results showed that in the context of
naphthalene-induced sensitization of K-RasG12D-driven
carcinogenesis, loss of Lmo4 reduced cell proliferation
and delayed the onset of transformation but did not affect
overall survival or tumor latency.
Methods
Mouse strains
K-RasLSL-G12D mice [28] and Shh-Cre mice [29] were
purchased from the Jackson laboratory. Lmo4fl/fl mice
were obtained from Prof Visvader (The Walter and Eliza
Hall Institute, Australia). Scgb1a1-creER mice were a kind
gift from Prof Hogan (Duke University) [30]. The Lmo4fl/fl
and Lmo4LacZ KI/+ mice have been described by Hahm
et al. [11]. All animal experiments were conducted ac-
cording to the Melbourne Health Research Directorate
Animal Ethics Committee guidelines. Mouse tail DNA
were genotyped by PCR using the following primers:








For bromodeoxyuridine (BrdU) immunodetection, mice
were injected with 0.5 mg per 10 g body weight 5-BrdU
cell labeling reagent (Amersham Biosciences) 1 h before
tissue collection. Naphthalene was dissolved in corn oil
and injected i.p. at 250 mg/kg. H1N1 virus (PR8 mouse
adapted virus; provided by A/Prof Belz, The Walter and
Eliza Hall Institute, Australia) was resuspended at 10
PFU in 25μL of Dulbecco’s Phosphate-Buffered Saline
(DPBS, Gibco) and administered by intranasal (i.n.) in-
stillation. Adenovirus Ad5-CMV-Cre (University of Iowa
Gene Transfer Vector Core) was resuspended in DPBS
(1010 PFU/ml) and was administered intra nasally (i.n.;
20μL per mouse).
Antibodies
For immunohistochemistry and immunofluorescence stain-
ing, the antibodies were α-LMO4 (clone 20F8, 7μg/ml),
α-BrdU (Accurate Chemical and Scientific Corporation,
OBT0030), α-keratin-5 (Covance, PRB-160P), α-Ki-67 (Cell
Signaling, D3B5), α-p63 (Biocare Medical, CM163), α-
CC10 (kind gift from Barry Stripp, Cedars-Sinai, CA), α-
FoxJ1 (e-Bioscience, 14-9965), α-Nkx2.1 (Dako, M3575).
Secondary antibodies were anti-rat biotin (Vector), anti-
rabbit Alexa 594, anti-goat Alexa 488, anti-mouse Alexa
488 (Molecular Probes). Immunofluorescence stainings
were imaged using DeltaVision Elite widefield microscope.
Human sections were stained with α-TTF1 (DAKO, clone
8G7G3/1) or α-p63 (Millipore, MAB4135) antibodies. For
Western blotting, α-LMO4 (clone 20F8) and α-GAPDH
(Sigma-Aldrich, 71.1) antibodies were used.
Histology and staining
For histological examination, lungs were fixed in 4 %
paraformaldehyde in phosphate-buffered saline (PBS),
embedded in paraffin, sectioned (2 μm) and stained with
haematoxylin and eosin. For immunohistochemistry,
sections were blocked in 10 % serum prior to incubation
with specific antibodies or an isotype-matched control
anti-rat (Pharmingen) or anti-rabbit (Cell Signaling) anti-
body diluted in PBS, 0.1 % tween containing 5 % serum,
followed by biotin-conjugated secondary anti-rat or anti-
rabbit antibody (Vector). Signal was amplified using Vec-
tastain Elite ABC Reagent (Vector) for 30 min followed by
3, 3′-diaminobenzidine (DAKO).For β-galactosidase activity staining, sorted cells were
cytospun and fixed in 2 % paraformaldehyde, 0.2 % glu-
taraldehyde, 0.8 % NP-40, 0.01 % Na-deoxycholate for
5min at room temperature. Slides were then washed in
PBS and stained with β-galactosidase staining solution (5
mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, 0.8 %
NP-40, 0.01 % Na-deoxycholate, 1 mg/ml X-gal) over-
night at 37 °C. Slides were then counterstained with
Nuclear-Fast Red and coverslipped.
Images of BrdU stained lung sections from Naphtha-
lene injury and K-RasG12D models were acquired on
Aperio ScanScope AT Slide Scanner (Leica Biosystems)
and analysed with FIJI image processing software (http://
fiji.sc). For Naphthalene injury model, BrdU positive
cells were scored manually on the scanned images and
number of positive cells in each airway was normalised
to the length of airway circumference. Number of BrdU
positive cells in hyperplastic airways at the week 12 time
point was quantified using a custom FIJI script based on
colour deconvolution and thresholding. The number of
BrdU positive cells was normalised to the area of the
corresponding hyperplastic airway and statistical analysis
was carried out at the level of individual airways. For
quantification of proliferating cells in hyperplastic air-
ways at day six time point, number of BrdU positive cells
normalised to area was calculated as above and averaged
for each mouse based on ten airways per mouse. Statistical
analysis was then performed at the mouse level. Tumour
areas in K-RasG12D model was measured manually on the
scanned images. Measurements were log transformed
and statistical analysis was carried out at the level of
individual tumours.
RNA isolation and Real Time PCR
Total RNA was extracted from lung tissue using the miR-
Neasy Mini Kit (Qiagen) according to manufacturer’s in-
structions. DNase treatment was performed using TURBO
DNA-free Kit based on the company’s instructions. cDNA
was generated using SuperScript III (Invitrogen) according
to the manufacturer’s instructions. qPCR was performed
using the Sensimix SYBR Hi-Rox kit (Bioline) and the
following primers for Lmo4: forward, 5′- CATGTTCT
ACCTGCCGGAAT-3′ reverse: 5′-TCTGGTCTGGCAG
TAGTGGA-3′. PCR was carried out in the Rotorgene RG-
6000 and expression levels were normalized against the
expression of 18S rRNA using the following primers: for-
ward, 5′-GTAACCCGTTGAACCCCATT-3′; and reverse
5′-CCATCCAATCGGTAGTAGCG-3′.
Fluorescent Activated Cells Sorting (FACS)
For FACS analysis, lungs were digested in collagenase
(1mg/ml collagenase in 3ml DPBS + 0.2g/L glucose per
lung) at 37 °C for 60 min while shaking at 165 rpm,
followed by red blood cell lysis with 0.64 % ammonium
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pended in blocking solution (anti-FcR and Rat IgG)
and incubated on ice for 10 min. Cells were stained
with conjugated antibodies CD31-PECy7, CD45-PECy7,
EpCAM-APC, CD104-FITC and CD24-PE (Biolegend) as
described previously [32]. Cells were then washed and re-
suspended in PI solution. Cells were sorted on an ARIA II
(Beckton Dickinson).
Tissue microarray analysis
Tissue microarrays (2 mm cores, 3 per patient) were cre-
ated from 34 squamous cell carcinomas, 40 adenocarcin-
omas and 10 otherwise classified Non Small Cell Lung
Cancer (NSCLC) including large cell carcinomas cases
collected from patients who underwent lung cancer sur-
gery. Samples were obtained via the Victorian Cancer
Biobank (Melbourne Australia). This study has Ethical
Committee approval (Walter and Eliza Hall Institute
Human Research Ethic Committee number 10/04). The
scoring system for intensity was as follows: 0 - no stain-
ing; one - weak staining; two - moderate staining; and
three - strong staining; and the scoring system for per-
centage was as follows: 0, no cells staining positive for
LMO4; 1 - ≤ 10 % cells staining positive; 2 - 11 % to 50
% positive cells; 3 - 51 % to 80 % positive cells; and 4 - ≥
80 % positive cells. The final histoscore (range from 0 to
12) was obtained from the product of the nuclear staining
intensity and percentage of stained cells and averaged be-
tween three separate tissue cores from each of the patients.
Difference in LMO4 histoscores between the cancer types
was tested using Wilcoxon rank sum test.
Statistical analysis
All statistical analysis was carried out using R software
[33]. Overall survival difference between genotypes was
tested by log rank test. To determine survival difference
between each pair of the genotypes, log rank test was
carried out on all pair-wise comparisons and resulting p
values were adjusted for multiple comparisons using
Holm method.
Unless otherwise specified, difference between means
was tested using one-way ANOVA after assuring that as-
sumptions of normality and equality of variance were satis-
fied. In cases, where residual errors did not follow normal
distribution, variables were log transformed. Where neces-
sary, p values were adjusted for multiple testing using
Tukey HSD method.
Differences in the number of BrdU positive cells in the
airways following Naphthalene injury (in normal and K-
RasG12D lungs) were analysed using Wilcoxon rank sum
test to accommodate multiple zero values.
Gene expression data for lung adenocarcinomas and
squamous cell carcinomas was obtained from the respect-
ive public RNA-seq datasets (IlluminaHiSeq_RNASeq) ofTCGA Research Network (http://cancergenome.nih.gov,
accessed on 18/07/2014) [34, 35]. Raw count data was fil-
tered to exclude lowly expressed genes (average log counts
per million (cpm) < 0) and normalised using TMM nor-
malisation in edgeR [36]. Log cpm values for LMO4 were
calculated across the samples using normalised library
sizes and difference in LMO4 expression between the can-
cer types was tested using one-way ANOVA.
Results
Lung-specific Lmo4 conditional knock-out mice display
normal lung development
We first examined the expression of Lmo4 during em-
bryonic lung morphogenesis, after birth and in adult.
Quantitative RT-PCR results showed low levels of Lmo4
expression in the early phase of embryonic development
from E11.5 to E15.5. Lmo4 expression peaks at E16.5
and then decreases in adult tissue (Additional file 1:
Figure S1A). To further analyse the expression pattern
of Lmo4 during embryonic lung development we per-
formed immunofluorescence co-staining for Lmo4 and
Nkx2.1, a marker of lung epithelial cells. Dynamic
changes in the expression pattern of Lmo4 were ob-
served (Fig. 1a). At E13.5, Lmo4 expression is detected
in both the mesenchymal and endodermal compartments
of the lung (Fig. 1a). At E16.5, strong Lmo4 expression is
observed in the endoderm of the conducting airways while
its expression is reduced in the distal branches from which
the alveoli will form (Fig. 1a). At E18.5 the expression of
Lmo4 becomes restricted to the cells lining the airways
(Fig. 1a). Further evaluation of Lmo4 expression in adult
lung shows that Lmo4 is expressed in club cells and cili-
ated cells, as shown by co-staining with CC10 and
FoxJ1, markers of club cells and ciliated cells respect-
ively (Fig. 1b). These results were confirmed by FACS
analysis where lung epithelial cells were sorted based on
the expression of EpCAM, CD104 (integrin β4) and
CD24 (Heat Stable Antigen) as previously described by
McQualter et al. [24] (Fig. 1c). Using these markers,
EpCAM+ epithelial cells can be subdivided into CD104+
cells enriched in alveolar cells, CD104+CD24lo cells
enriched for club and progenitor cells and CD104+CD24hi
cells enriched in ciliated cells [24]. Using Lmo4LacZKi/+
mice in which the LacZ transgene has been knocked
into the Lmo4 locus [9] we observed β-galactosidase
staining in CD104+CD24lo and CD104+CD24hi cells in-
dicating that Lmo4 is expressed in CD104-positive cells
(Fig. 1d).
To explore the role of Lmo4 in the lung epithelium,
we generated Shh-cre;Lmo4fl/fl mice in which Lmo4 was
excised from E9.5 in the epithelium of the lung primor-
dia. Since the cre allele was knocked into the Shh locus
resulting in loss of one Shh allele, Shh-cre;Lmo4fl/+
animals were used as controls. Shh-cre;Lmo4fl/fl pups
Fig. 1 Lmo4 is expressed in lung epithelial cells. a Immunofluorescence staining for Nkx2.1 (green) and Lmo4 (red) in embryonic lung. Scale
bars = 25 μm. b Immunofluorescence staining for CC10, FoxJ1 and Lmo4 in adult lung. Scale bars = 50 μm. c Representative FACS plots showing
the sorting strategy to isolate adult lung epithelial subpopulations from live CD31−CD45− cells. EpCAM−CD104−: non epithelial cells; EpCAM
+CD104+ (also known as integrin β4): enriched in alveolar cells; EpCAM+CD104+CD24lo (CD24lo): enriched in club cells and progenitor cells;
EpCAM+CD104+CD24hi (CD24hi): enriched in ciliated cells. d Representative photos of X-Gal and Nucleo-Fast Red counterstaining of sorted lung
subpopulations isolated from Lmo4LacZKI/+ mice. Scale bars = 50 μm
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adulthood without any lung abnormalities compared to
controls (Additional file 1: Figure S1B and data not
shown), although complete excision of Lmo4 was ob-
served in the epithelium of Shh-cre;Lmo4fl/fl embryos
(Additional file 1: Figure S1B). These results demon-
strate that although Lmo4 is expressed in the embryonic
lung, its role in the epithelium is not essential for nor-
mal lung morphogenesis.Loss of Lmo4 affects lung repair after H1N1-induced lung
injury
Given that Lmo4 is expressed in CD104-positive cells
that have recently been described to participate in the
regeneration of the epithelium after flu-mediated lung
injury [22], we investigated whether Lmo4 was required
for adult lung progenitor cell function. We first observed
that under steady state conditions, the number of
CD104+ cells was reduced in Shh-cre;Lmo4fl/fl compared
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when plated in colony formation assay on matrigel, the
remaining CD104+ cells present in Shh-cre;Lmo4fl/fl
lungs had the same colony formation capacity as control
animals (data not shown). These results suggested thatFig. 2 Loss of Lmo4 results in impaired lung repair following H1N1 infectio
or Shh-cre;Lmo4fl/fl animals. Data represent mean ± S.E.M., n = 5 animals per
expression of Lmo4, keratin 5 and p63 in wild-type lungs 11 days post infe
showing the survival of Shh-cre;Lmo4fl/fl animal (n = 27) compared to control a
H&E and immunohistochemistry showing the expression of keratin 5, p63 and
days post infection with H1N1 (10PFU). Scale bars = 50 μmloss of Lmo4 does not affect CD104+ progenitor cells
colony forming capacity in vitro.
To further explore the role of Lmo4 in vivo we
infected Shh-cre;Lmo4fl/fl and control mice with H1N1
flu virus. Intra-nasal administration of murine adaptedn. a Percentage of EpCAM+CD104+ cells in the lungs of naïve control
group. b Representative immunofluorescence staining showing the
ction with H1N1 PR8 (10PFU). Scale bars = 25 μm. c Kaplan-Meier curve
nimals (n = 69) following infection with PR8 flu virus. d Representative
the proliferation marker Ki67 in control and Shh-cre;Lmo4fl/fl mice 11
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chiolar and alveolar damage, with loss of club cells, cili-
ated cells and alveolar type 2 cells [20]. In the damaged
areas, proliferation is maximal at 11 days post-infection
and is driven by CD104-positive keratin 5-positive distal
basal cells [20–22]. Interestingly, Lmo4 is expressed in
these regions of active proliferation with keratin 5-positive
cells expressing Lmo4 (Fig. 2b). Co-staining for Lmo4 and
p63, another marker of basal cells, was also observed
(Fig. 2b). Shh-cre;Lmo4fl/fl mice showed an increased sen-
sitivity to H1N1 infection with only 68 % of animals sur-
viving to 11 days post infection compared to 89 % in the
control group (Fig. 2c, log rank test p = 0.028, n ≥ 27). In
both genotypes, animals that survived to 11 days recov-
ered and returned to normal health within a few days.
Interestingly, however, loss of Lmo4 was associated with a
significant reduction in the percentage of keratin 5 ex-
pressing cells and Ki67-positive proliferating cells after
H1N1 infection (Fig. 2d). Reduced animal recovery (68 %)
and lower proliferation in Lmo4-depleted animals that
survive the injury, suggest that Lmo4 is required for the
proliferation of lung epithelial cells for the repair of the in-
jured lung but is not essential for progenitor cells activity
after flu-mediated injury.
Loss of Lmo4 affects lung repair after naphthalene-induced
lung injury
Lmo4 expression in club cells in adult airways suggested
that it might play an important role in repair after air-
way injury [37]. Treatment of mice with naphthalene
damages the club cells lining the bronchiole with max-
imal injury of the airways observed two days following
naphthalene treatment [26, 38]. Repair of the epithelium
is driven by a population of variant club cells that are
resistant to naphthalene-induced injury with newly re-
generated epithelium observed one week after treatment
[38]. In wild-type mice, although the majority of club
cells are depleted two days after naphthalene injection,
Lmo4 was detected in cells lining the airways at this
time point (Fig. 3a). Interestingly, staining for the prolif-
eration marker Ki67 revealed the presence of prolifera-
tive cells in the layer of flattened Lmo4-positive cells
lining the basement membrane of the bronchiole four
days following injury (Fig. 3a). Six days following injury,
the number of proliferative cells increased and these cells
co-expressed Lmo4 (Fig. 3a), suggesting that Lmo4 may
play a role in lung epithelial cell proliferation after naph-
thalene injury. To explore the role of Lmo4 in airway re-
pair following naphthalene injury, Shh-cre;Lmo4fl/fl mice
were treated with naphthalene and the lungs collected to
analyse proliferation and airway repair. Lmo4 loss resulted
in delayed repair with a reduction in the number of
CC10-positive club cells five days post-naphthalene ad-
ministration compared to control animals (Fig. 3b). BrdUimmunostaining further showed a reduction in the
number of proliferative cells in Shh-cre;Lmo4fl/fl lungs
compared to control (Fig. 3c and d, Wilcoxon rank sum
test p = 0.0002). However, the animals survived the in-
jury and eventually, the airways of Shh-cre;Lmo4fl/fl mice
returned to normal (data not shown). These results
were confirmed using Scgb1a1-creER;Lmo4fl/fl mice in
which deletion of Lmo4 occurs specifically in club cells
after tamoxifen administration [30] (Additional file 2:
Figure S2A). Scgb1a1-creER;Lmo4fl/fl mice were first
treated with corn oil or tamoxifen followed by naphtha-
lene 2 weeks later. Analysis of BrdU incorporation in
the lung five days after injury showed a significant re-
duction in the number of BrdU-positive cells in the air-
ways of tamoxifen-treated mice (Fig. 3e, Wilcoxon rank
sum test p = 0.039), consistent with the data observed in
Shh-cre;Lmo4fl/fl mice. These results suggest that Lmo4
promotes proliferation of epithelial cells after naphthalene-
induced injury but is dispensable for complete repair of
the airways.
Loss of Lmo4 delays initiation of hyperplasia in
K-RasLSL-G12D/+ mice sensitized with naphthalene
Administration of naphthalene following K-RasG12D acti-
vation results in earlier tumor onset and increased tumor
burden due to activation of progenitor cells in response to
injury [27]. Given that Lmo4 is involved in the regulation
of the proliferation of epithelial cells after naphthalene
injury, we assessed whether loss of Lmo4 would affect
initiation of tumor growth in naphthalene-mediated
sensitization of K-RasG12D-driven tumors. We used K-
RasLSL-G12D model in which cre-mediated excision of
the “STOP” cassette by intranasal administration of
cre-expressing adenoviruses leads to activation of the
oncogenic K-RasG12D in the lung [28, 39]. Upon Ad5-
CMV-Cre infection, these mice initially develop aden-
omatous hyperplasia, which progresses to adenomas
and adenocarcinomas [28]. K-RasLSL-G12D/+;Lmo4fl/fl,
K-RasLSL-G12D/+;Lmo4fl/+ and K-RasLSL-G12D/+;Lmo4+/+
mice were infected with Ad5-CMV-cre resulting in acti-
vation of K-RasG12D and excision of Lmo4 alleles in lung
cells, followed one week later by naphthalene adminis-
tration. Lungs were collected for analysis six days after
naphthalene injection. At this time-point, areas of hyper-
plastic epithelium were observed around the airways of
control animals but not in K-RasLSL-G12D/+;Lmo4fl/fl mice
(Fig. 4a). Consistently, there was a marked decrease in the
number of BrdU-positive cells in K-RasLSL-G12D/+;Lmo4fl/fl
compared to K-RasLSL-G12D/+ mice (Fig. 4a and b, one-way
ANOVA p = 0.03, n ≥ 3). However, when lungs were col-
lected 11 weeks following naphthalene injury (12 weeks
following Ad5-CMV-cre administration), the number of
proliferating cells in the hyperplastic airways was indis-
tinguishable between the genotypes (Fig. 4c and d,
Fig. 3 (See legend on next page.)
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Fig. 3 Loss of Lmo4 results in delayed repair after naphthalene-induced injury. a Representative immunofluorescence staining showing
co-expression of Lmo4 (red) and Ki67 (green) in cells lining the airways of mice treated with naphthalene at the indicated time points. Scale
bars = 50μm. White arrows indicate Ki67/Lmo4 double positive cells. b Immunohistochemistry showing the expression of the club cell marker
CC10 in control and Shh-cre;Lmo4fl/fl lung sections 4, 5 and 6 days following naphthalene administration. Scale bars = 50μm. c BrdU staining of
control and Shh-cre;Lmo4fl/fl lung sections five days following naphthalene administration. Scale bars = 50μm. Arrows indicate BrdU-positive
cells. d Bar graph showing the number of BrdU-positive cells per airway circumference of control and Shh-cre;Lmo4fl/fl mice five days following
naphthalene injury. Data represent mean ± S.E.M., n ≥ 39 airways per group from at least three animals per group. e Bar graph showing the
number of BrdU-positive cells per airway circumference of control and Scgb1a1-creER;Lmo4fl/fl mice five days following naphthalene injury. Data
represent mean ± S.E.M., n ≥ 47 airways per group from at least three animals per group. p-value computed by Wilcoxon rank sum test
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shown) and tumor area in the parenchyme (Additional
file 2: Figure S2B) were also similar between the groups.
These results indicate that loss of Lmo4 delays initiation
of hyperplasia after naphthalene injury but this effect is
rapidly overcome by signaling pathways activated by
K-RasG12D.Fig. 4 Loss of Lmo4 affects early stages of K-RasG12D-induced cell proliferation
+Lmo4+/+ lungs six days following naphthalene injection. Scale bars = 100μm.
b Quantification of the number of BrdU+ cells per unit of airway area in K-Ras
mice six days following naphthalene injection. n ≥ 3 animals per group. c H&E
hyperplastic airways 11 weeks post naphthalene administration. Mice received
100μm. d Quantification of the number of BrdU+ cells in K-RasLSL-G12D/+;Lmo4fl
administration. Mice received Ad5-CMV-cre one week prior to naphthalene tr
The graph represents mean ± S.E.M., n ≥ 26 hyperplastic airways per group (nLoss of Lmo4 does not affect tumor progression in
K-RasG12D-driven mouse model of lung cancer
We then assessed whether Lmo4 participated in tumor
growth in the K-RasLSL-G12D model in the absence of
naphthalene sensitization. K-RasLSL-G12D/+, K-RasLSL-G12D/+;
Lmo4fl/+ and K-RasLSL-G12D/+;Lmo4fl/fl mice were infected
intra-nasally with Ad5-CMV-cre resulting in activation of. a H&E and BrdU staining of K-RasLSL-G12D/+;Lmo4fl/fl and K-RasLSL-G12D/
Dashed line shows region used for quantification of BrdU staining.
LSL-G12D/+;Lmo4fl/fl, K-RasLSL-G12D/+;Lmo4fl/+ and K-RasLSL-G12D/+;Lmo4+/+
and BrdU staining of K-RasLSL-G12D/+;Lmo4fl/fl and K-RasLSL-G12D/+Lmo4+/+
Ad5-CMV-cre one week prior to naphthalene treatment. Scale bars =
/fl and K-RasLSL-G12D/+;Lmo4+/+ mice at 11 weeks post naphthalene
eatment. Data represent number of BrdU+ cells per unit of airway area.
≥ 3 animals per group)
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cells. Survival analysis showed no significant difference
in the survival of K-RasLSL-G12D/+;Lmo4fl/fl mice (median
survival 128 days, n = 13), when compared with K-
RasLSL-G12D/+;Lmo4fl/+ (median survival 141 days n = 22)
and K-RasLSL-G12D/+ (median survival 157 days, n = 20)
control animals (Fig. 5a, log rank test p = 0.06). Histo-
logical examination and analysis of lung weight upon
collection at ethical endpoint showed no significant dif-
ference in tumor burden in Lmo4-depleted lungs com-
pared to control mice (Fig. 5b and c, one-way ANOVA
p = 0.33, n ≥ 13), although Lmo4 expression was reduced
in the tumors as assessed by Western Blot (Additional
file 2: Figure S2C). All tumors presented histologicalFig. 5 Loss of LMO4 does not alter overall survival in mouse model of lung
+;Lmo4fl/fl, K-RasLSL-G12D/+;Lmo4fl/+ and K-RasLSL-G12D/+;Lmo4+/+ mice following
H&E showing overall tumour burden in K-RasLSL-G12D/+;Lmo4fl/fl and K-RasLSL-
K-RasLSL-G12D/+;Lmo4fl/fl, K-RasLSL-G12D/+;Lmo4fl/+ and K-RasLSL-G12D/+ mice at eth
represents mean ± S.E.M., n ≥ 13 animals per group. d Immunohistochemist
and K-RasLSL-G12D/+;Lmo4+/+ tumours. Scale bars = 50μm. e Representative H&E
airways 12 weeks following intranasal administration of Ad5-CMV-cre. Scale b
airways of K-RasLSL-G12D/+;Lmo4fl/fl and K-RasLSL-G12D/+ mice at 12 weeks pos
per unit of airway area. The graph represents mean ± S.E.M., n ≥ 18 hyperpfeatures of adenocarcinomas and detailed morphological
analysis did not show any significant difference in tumor
grade, number of mitosis, presence of atypical adenoma-
tous hyperplasia or bronchial hyperplasia between any
of the genotypes (data not shown). Immunostaining for
TTF-1, a marker of adenocarcinoma, and Sox2, a
marker present in early lesions originating from CC10-
positive cells and lost in advanced adenocarcinoma [40],
revealed no difference between K-RasLSL-G12D/+;Lmo4fl/fl
and K-RasLSL-G12D/+ mice (Fig. 5d).
To evaluate whether loss of Lmo4 could affect tumour
initiation, we collected mice of each genotype 12 weeks
after Ad5-CMV-cre administration. Given that Lmo4 is
essentially expressed in the airways, we quantified thecancer. a Kaplan-Meier curve showing overall survival of K-RasLSL-G12D/
cre recombination with Ad5-CMV-cre adminstration. b Representative
G12D/+;Lmo4+/+ mice. Scale bar = 2mm. c Average lung weight of
ical endpoint collection indicating overall tumor burden. The graph
ry showing the expression of TTF-1 and Sox2 in K-RasLSL-G12D/+;Lmo4fl/fl
staining of K-RasLSL-G12D/+;Lmo4fl/fl and K-RasLSL-G12D/+;Lmo4+/+ hyperplastic
ars = 100μm. f Quantification of the number of BrdU+ cells in hyperplastic
t Ad5-CMV-cre administration. Data represent number of BrdU+ cells
lastic airways per group (n ≥ 3 animals per group)
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and found no difference between Lmo4-depleted and
control lungs (Fig. 5e and f, Wilcoxon rank sum p =
0.2773). Analysis of the lung weight (data not shown) or
tumor area (Additional file 2: Figure S2D) did not show
any significant difference between the cohorts. These re-
sults indicate that Lmo4 is not essential for tumor cell
proliferation and overall tumor growth in the K-RasG12D-
induced mouse model of lung cancer.
LMO4 is expressed in human lung squamous cell carcinoma
Gene expression profiling analysis of lung tumors showed
that LMO4 is highly expressed in advanced adenocarcin-
omas, which prompted us to analyse its role in K-RasG12D
mouse model of adenocarcinoma [15]. As we did not ob-
serve any effect of Lmo4 loss on tumor-free survival in
this model, we decided to further determine LMO4 ex-
pression in the different subtypes of NSCLC in early stage
disease. We performed immunostaining for LMO4 in
NSCLC tissue-microarray (TMA) of lung cancer sam-
ples obtained from patients undergoing lung cancerFig. 6 LMO4 is expressed in early stage lung squamous cell carcinoma. a R
of TTF-1, p63 and LMO4 in human NSCLC cancer tissue microarray (TMA). S
in TMA for adenocarcinomas and squamous cell carcinomas (mean ± S.E.M
million) in lung adenocarcinoma (Adeno) and squamous cell carcinoma (Sqsurgery (stage I-II disease) comprising 34 squamous cell
carcinomas, 40 adenocarcinomas and ten otherwise-
classified NSCLCs including large cell carcinomas. Scor-
ing of LMO4 expression showed that LMO4 was signifi-
cantly more expressed in squamous cell carcinomas
compared to other tumor types (Fig. 6a and b, Wilcoxon
rank sum test, p < 0.001). Consistently, analysis of The
Cancer Genome Atlas (TCGA) data showed an increase
in LMO4 expression in lung squamous cell carcinomas
(n = 224) compared to adenocarcinomas (n = 125) (Fig. 6c,
one-way ANOVA p < 0.0001). These results suggest that
LMO4 may play a more prominent role in the pathology
of early stage squamous cell carcinoma than in adenocar-
cinomas. Depletion of Lmo4 in a mouse model of lung
squamous cell carcinoma would enable to further explore
this hypothesis.
Discussion
Identifying factors regulating lung progenitor cell activity
following lung injury is instrumental to deciphering pro-
cesses driving lung repair. With their distinct properties toepresentative immunohistochemistry images showing the expression
cale bars = 50μm. b Plot showing the histoscore for LMO4 expression
.). c Box plot showing LMO4 expression levels (LogCPM: log count per
CC) RNAseq data from TCGA
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genitor cells, H1N1 infection and naphthalene treatment
constitute complementary approaches to evaluate the role
of particular proteins in the regulation of lung repair. Our
results show that Lmo4 participates in the regulation of
lung epithelial cell proliferation in these two models of in-
jury. Lmo4 is dispensable for epithelial repair and animal
survival but its loss delays recovery and increases sensitiv-
ity to H1N1-mediated injury. We also show that Lmo4
participates in the onset of lung cell proliferation induced
by naphthalene in the context of oncogenic K-RasG12D,
further suggesting that Lmo4 plays an important role in
lung epithelial cell proliferation.
Lmo4 is expressed in the developing lung with its ex-
pression becoming restricted to the airway lineages dur-
ing development. This pattern of expression of Lmo4 in
the embryonic lung is reminiscent of the expression
profile of the transcription factor Sox2 where Sox2 is
expressed only in the proximal airways and is absent in
the distal tips of the branching epithelium that expresses
Sox9 [41, 42]. Similar to Sox2, the expression pattern of
Lmo4 becomes restricted to club cells and ciliated cells in
the adult lung and is absent in the alveoli [42]. Given that
half of Lmo4-/- mice present breathing difficulties and die
shortly after birth [11] we investigated the role of Lmo4
during lung morphogenesis by specifically ablating its ex-
pression in the lung epithelium from E9.5. No lung defects
were observed in the conditional knock-out animals and
their survival to adulthood was similar to their littermate
controls. We observed that Lmo4 is expressed in both the
epithelium and the mesenchyme until E13.5 before be-
coming restricted to the epithelium. Deletion of Lmo4
specifically in the mesenchyme would be required to
evaluate whether Lmo4 plays a critical role in the mesen-
chyme during early lung morphogenesis.
Lmo4 has been implicated in the proliferation of pro-
genitor cells in normal neural crest development where
knockdown of Lmo4 leads to loss of neural crest precur-
sor formation at the neural plate border [5] prompting
us to evaluate the role of Lmo4 in lung progenitor cell
activity. Repair of the adult lung is mediated by different
progenitor cells depending on the type of injury inflicted.
Following naphthalene administration, a rare population
of variant club cells that do not express Cyp2f2 is main-
tained and responsible for the repopulation of the cells
lining the airways [26, 30]. On the other hand, recent
lineage tracing experiments showed that a rare popula-
tion of keratin-5 positive basal cells present in the distal
lung expand after flu injury to repair the lung [21] indi-
cating that distinct progenitor cell populations are in-
volved in the repair processes following naphthalene or
H1N1 injury. Our results show that Lmo4 promotes epi-
thelial cell proliferation in both models of lung injury.
However, in vitro colony formation assay did not showany significant difference in the progenitor activity of
Lmo4 conditional knockout cells compared to control
cells, suggesting that Lmo4 may participate in cell prolifer-
ation but is not essential for lung progenitor cell function.
Consistently, animals with Lmo4-depleted lungs manage
to eventually recover from injury. Knock-down of Lmo4
has been shown to potentiate TGFβ signaling in HEK293
cells [10]. We previously showed that TGFβ inhibited lung
epithelial cell colony formation capacity in vitro while
SB431542, an inhibitor of TGFβ signaling, increased col-
ony forming capacity in vitro [43]. Loss of Lmo4 in Shh-
cre;Lmo4fl/fl mice may therefore increase TGFβ signaling
resulting in reduced epithelial cell proliferation. Other
factors have been implicated in the proliferation of lung
progenitor cells such as Bmi1 which regulates bronchio-
alveolar stem cells (BASCs) expansion following naphtha-
lene injury [44], p38α and PTEN which are involved in
the expansion of BASCs [45, 46]. Stabilisation of β-catenin
has also been shown to accelerate repair and increase
CC10 expression three days following naphthalene injury
[47]. Factors regulating distal basal cell expansion after
H1N1 injury are still undefined. Lmo4 most likely cooper-
ates with other regulatory factors to enable progenitor
cells expansion and repair of the injured lung.
Recent studies have investigated the cell of origin of
the different subtypes of lung cancer. Induction of onco-
gene expression or loss of tumor suppressor genes in
specific cellular compartments using adenoviral delivery
or genetically modified mouse models showed that neu-
roendocrine cells were the most likely cell of origin of
small cell lung cancer [48] while both CC10-positive
club cells and alveolar type II cells are involved in the
initiation of tumor growth in K-RasLSL-G12D/+- or K-
RasLSL-G12D/+;p53+/--induced adenocarcinoma [40, 49].
In these models, expansion of CC10-positive cells after
naphthalene injury has been described [40]. We observed
that Lmo4 is expressed in club cells and is present in
remaining proliferating cells lining the airways after naph-
thalene injury. Interestingly, Lmo4 deletion reduced cell
proliferation after naphthalene injury in K-RasLSL-G12D/+
mice, suggesting that upon K-RasG12D expression, Lmo4 is
required for optimal proliferation of CC10-positive cells
resistant to naphthalene injury. However this initial effect
on cell proliferation is not observed 12 weeks following in-
jury suggesting that Lmo4 is redundant for long-term
KrasG12D-driven tumorigenesis. Using CMV-cre adenovi-
ruses to activate K-RasG12D expression and deplete Lmo4
expression, we targeted all cell types in the lung, includ-
ing alveolar type II cells that are the predominant cell of
origin in K-RasG12D-induced adenocarcinoma [40, 49]
but do not express Lmo4. The lack of difference in over-
all survival between K-RasLSL-G12D/+;Lmo4fl/fl and K-
RasLSL-G12D/+ mice may therefore reflect the initiation of
adenocarcinoma formation in alveolar type II cells.
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sively in CC10-positive cell would enable to resolve this
hypothesis. However, given that the role of Lmo4 in pro-
genitor cells is redundant, it is also likely that in the con-
text of oncogenic transformation, Lmo4 is important in
the early phase of transformation but is rapidly taken over
by other factors controling transformed cell proliferation.
LMO4 is overexpressed in 50 % of breast cancer and
83 % of pancreatic adenocarcinoma [3, 50]. In lung can-
cer, gene expression analysis showed that LMO4 is over-
expressed in SCLC and advanced adenocarcinoma [15]
but its expression has not been investigated in early
stage disease in NSCLC. The association between LMO4
expression and patient outcome is still unclear. High
LMO4 expression is associated with worse outcome in
breast cancer [3] while in pancreatic adenocarcinoma,
low LMO4 expression is associated with poor outcome
[50]. In head and neck squamous cell carcinomas, LMO4
has been reported to be overexpressed at the invasive
front of the tumor but its expression did not correlate
with patient outcome [13, 51]. In a cohort of 84 NSCLC
resected specimen from patients with stage I and II dis-
ease, we found that LMO4 expression was significantly
higher in squamous cell carcinoma compared to adeno-
carcinoma. The size of the cohort in our current study did
not enable us to evaluate correlation with patient out-
come. Further investigations will be necessary to evaluate
whether LMO4 is a predictor of outcome in lung squa-
mous cell carcinoma and whether it plays a role in squa-
mous cell carcinoma tumor progression. Lung squamous
cell carcinoma is mostly observed in smokers. Our results
show that loss of Lmo4 delays repair in acute models of
lung damage such as naphthalene and H1N1 injury. It
would be of interest to explore whether Lmo4 plays a
prominent role in the repair of the lung in long-term in-
jury models observed after exposure to oxidant such as
cigarette smoke or ozone [52]. A role for Lmo4 in the
regulation of cells proliferation in long-term injury may
provide information regarding its role in the pathology of
lung squamous cell carcinoma.
Conclusions
Factors regulating lung repair following chemical or
viral damage are still largely unknown. Here we show
that the transcriptional regulator Lmo4 promotes lung
epithelial cell proliferation and tissue repair following
injury. Additionally, Lmo4 was found to modulate the
early proliferative response observed after activation of
oncogenic K-RasG12D expression in the context of naph-
thalene sensitization, although loss of Lmo4 did not
affect overall tumor-free survival. This work provides
novel insights into factors regulating lung repair follow-
ing tissue damage caused by chemicals and pathogens
present in the environment.Additional files
Additional file 1: Figure S1. Expression of Lmo4 in epithelial cells is
not required for embryonic lung morphogenesis. (A) qRT-PCR analysis of
Lmo4 expression from E11.5 to E18.5, one week post-natal (Pn) and adult
wild type lung (n = 4). Graph represents mean ± S.E.M. (B) Representative
images showing immunohistochemistry for Lmo4 and Ki67 in sections of
control and Shh-cre;Lmo4fl/fl embryonic lung. Scale bars = 50μm.
Additional file 2: Figure S2. Lmo4 expression is lost in Scgb1a1-
creER;Lmo4fl/fl mice and K-RasLSL-G12D/+;Lmo4fl/fl mice. (A) Representative
images showing immunohistochemistry for Lmo4 in sections of Scgb1a1-
creER;Lmo4fl/fl mice treated with corn-oil or tamoxifen. Scale bars = 50μm.
(B) Quantification of tumor size in K-RasLSL-G12D/+;Lmo4fl/fl, K-RasLSL-G12D/+;
Lmo4fl/+ and K-RasLSL-G12D/+ mice at 11 weeks post naphthalene administration.
Mice received Ad5-CMV-cre one week prior to naphthalene treatment. n ≥
26 tumors per group from at least 3 animals per group. (C) Western blot
analysis of Lmo4 expression in lung tumors isolated from K-RasLSL-G12D/+;
Lmo4fl/fl, K-RasLSL-G12D/+;Lmo4fl/+ and K-RasLSL-G12D/+ mice. (D) Quantification of
tumor size in K-RasLSL-G12D/+;Lmo4fl/fl, K-RasLSL-G12D/+;Lmo4fl/+ and K-RasLSL-G12D/+
mice at 12 weeks post administration of Ad5-CMV-cre. n ≥ 18 tumors per
group from at least three animals per group. Graphs represent mean log
tumour area ± S.E.M.
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